Document is current
Any future updates will be listed below
-
Authors
Green, Gilad Sahar
Fujita, Masashi
Yang, Hyun-Sik https://orcid.org/0000-0002-8318-0443
Taga, Mariko
Cain, Anael
McCabe, Cristin
Comandante-Lou, Natacha
White, Charles C.
Schmidtner, Anna K.
Zeng, Lu https://orcid.org/0000-0001-9381-7690
Sigalov, Alina
Wang, Yangling https://orcid.org/0000-0002-8589-4239
Regev, Aviv
Klein, Hans-Ulrich https://orcid.org/0000-0002-6382-9428
Menon, Vilas https://orcid.org/0000-0002-4096-8601
Bennett, David A.
Habib, Naomi https://orcid.org/0000-0002-6049-2487
De Jager, Philip L. https://orcid.org/0000-0002-8057-2505
- License Information
-
More Information
Article History
Received: 22 February 2023
Accepted: 24 July 2024
First Online: 28 August 2024
Competing interests
: A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was an scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. From 1 August 2020, A.R. is an employee of Genentech, a member of the Roche Group. The other authors declare no competing interests.
